In the present study we describe the synthesis, wet spinning, mechanical testing, and degradation of poly(urethane urea)s (PUURs) intended for clinical use in anterior cruciate ligament (ACL) reconstruction. The effects of soft segment chemical composition and molar mass and the kind of diamine chain extender on the material properties were investigated. It was found that the fibers made of PUUR with polycaprolactone diol (PCL530) as soft segment and MDI/1,3-DAP as hard segment (PCL530-3) have high tensile strength and high modulus and when degraded keep their tensile strength for the time demanded for the application. In conclusion, from a chemical and mechanical point of view PUUR fibers of PCL530-3, ARTELON, are suitable for designing a degradable ACL device.
The phase separation and morphology in poly(urethane urea)s were investigated as soft segment length and chain extender structure were varied. Increases in soft segment length led to increased phase separation that resulted in greater mobility of the soft segment. This was shown by lower soft segment glass transition temperatures in differential scanning calorimetry (DSC) as well as a shift of Emax″ and tan δmax to lower temperatures. Also the structure of the chain extender affected the degree of phase separation and mixing of the soft and the hard blocks in an interphase. Atomic force microscopy (AFM) was used to visualize the structure of the phase‐separated domains. The hard domains were in the form of spheres 5–10 nm, or long needles 5 nm thick and 50–300 nm long. As the soft segment length increased, there were more pure soft segment phase areas between the hard domains. At high hard segment content, a larger scale structure was found, consisting of both hard and soft segments.DSC thermograms of poly(urethane urea)s containing different soft segment lengths.magnified imageDSC thermograms of poly(urethane urea)s containing different soft segment lengths.
Full thickness skin wounds in humans heal with scars, but without regeneration of the dermis. A degradable poly(urethane urea) scaffold (PUUR), Artelon(R) is already used to reinforce soft tissues in orthopaedics, and for treatment of osteoarthritis of the hand, wrist and foot. In this paper we have done in vitro experiments followed by in vivo studies to find out whether the PUUR is biocompatible and usable as a template for dermal regeneration. Human dermal fibroblasts were cultured on discs of PUUR, with different macrostructures (fibrous and porous). They adhered to and migrated into the scaffolds, and produced collagen. The porous scaffold was judged more suitable for clinical applications and 4 mm Ø, 2 mm-thick discs of porous scaffold (12% w/w or 9% w/w polymer solution) were inserted intradermally in four healthy human volunteers. The implants were well tolerated and increasing ingrowth of fibroblasts was seen over time in all subjects. The fibroblasts stained immunohistochemically for procollagen and von Willebrand factor, indicating neocollagenesis and angiogenesis within the scaffolds. The PUUR scaffold may be a suitable material to use as a template for dermal regeneration.
A combination of measurement of mobility and orientational dynamics of long reptating DNA in agarose gel
has been used to reveal how the binding of Δ and Λ enantiomers of the tris(phenanthroline)ruthenium(II) ion
affects the flexibility of the DNA helix. The mobility data, and data over the step length and period time of
the reptation cycle, obtained in the presence of the respective enantiomer, are compared with those of free
DNA and with data obtained earlier on DNAs with known variations in helix flexibility. The results suggest
that the Δ form induces kinks in the DNA helix while the Λ form gives rise to a local stiffening of the helix.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.